ArticleLeukemia2022

Combined Drug Targeting of p53-dependent and -independent Pathways Depletes Myelofibrosis Hematopoietic Stem/Progenitor Cells.

Min Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.